ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9592
-0.14%
Brent Oil
83.175
0.06%
Bitcoin
64,089.80
0.14%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. AlloVir Inc (ALVR)

  7. AlloVir Inc (ALVR) Noticias

ALVR AlloVir Inc

0.798
-0.0085 (-1.05%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
AlloVir Inc ALVR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0085 -1.05% 0.798 23:00:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.81 0.7801 0.81 0.798 0.8065
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/3/202405:10PRNUSClass Action Filed Against AlloVir, Inc. (ALVR) Seeking..
07/3/202404:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
22/2/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202404:45PRNUSClass Action Filed Against AlloVir, Inc. (ALVR) Seeking..
21/2/202419:22EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:00EDGAR2Form 144 - Report of proposed sale of securities
15/2/202415:30EDGAR2Form RW - Registration Withdrawal Request
12/2/202415:34EDGAR2Form 8-K - Current report
09/2/202404:45PRNUSShareholders that lost money on AlloVir, Inc.(ALVR) Urged to..
06/2/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202419:00EDGAR2Form 144 - Report of proposed sale of securities
02/2/202404:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/1/202404:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202419:30EDGAR2Form 144 - Report of proposed sale of securities
09/1/202411:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202411:29EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202405:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
04/1/202417:00EDGAR2Form 144 - Report of proposed sale of securities
04/1/202416:21EDGAR2Form 8-K - Current report
22/12/202306:07EDGAR2Form 8-K - Current report
22/12/202306:00GLOBEAlloVir Provides Updates on Phase 3 Clinical Development..
21/11/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202316:00EDGAR2Form 144 - Report of proposed sale of securities
17/11/202316:30EDGAR2Form 144 - Report of proposed sale of securities
16/11/202306:00BWAlloVir to Present at the Piper Sandler 35th Annual..
02/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202307:11EDGAR2Form 8-K - Current report
02/11/202306:00BWAlloVir Reports Third Quarter 2023 Financial Results
23/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202316:00EDGAR2Form 144 - Report of proposed sale of securities
05/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202316:49EDGAR2Form 144 - Report of proposed sale of securities
28/8/202306:00BWAlloVir to Present at Upcoming Investor Conferences
21/8/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202316:00EDGAR2Form 144 - Report of proposed sale of securities
17/8/202316:07EDGAR2Form 144 - Report of proposed sale of securities
03/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202306:34EDGAR2Form 8-K - Current report
03/8/202306:00BWAlloVir Reports Second Quarter 2023 Financial Results
21/7/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202318:23EDGAR2Form 144 - Report of proposed sale of securities
12/7/202306:41IHMARKETNEWSWednesday’s Wall Street Highlights: Nvidia, VMware,..
06/7/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202316:49EDGAR2Form 144 - Report of proposed sale of securities
05/7/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/6/202320:20BWAlloVir Announces Pricing of Public Offering of Common Stock
21/6/202315:18BWAlloVir Announces Proposed Public Offering of Common Stock
05/6/202306:00BWAlloVir Presents Positive Final Results From A Phase 2..

Su Consulta Reciente

NASDAQ
ALVR
AlloVir
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados